Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Opportunities for Commercial-Academic Collaborations with Oxford Cancer Research

An event for Small-Medium Enterprises, SMEs, with cancer-related therapeutics or diagnostic assets who are in need of a tailored, strategic development pathway.

An introductory webinar for the newly established Clinical Positioning Network of the Oxford Cancer Centre

Featuring Prof Sarah Blagden & Prof Mark Middleton

This event is aimed at Small-Medium Enterprises with cancer-related therapeutics or diagnostic assets that require a tailored, strategic development pathway. In this webinar, you will hear from CPN academic and clinical leaders Prof Mark Middleton and Prof Sarah Blagden about the new chances and opportunities for SMEs to enter drug-development collaborations with Oxford. As well as how the CPN can help tailor your route into the clinic via commercial-academic partnerships with Oxford.

To register, click here.

About the CPN

The Oxford Cancer Clinical Positioning Network (CPN) is an Oxford-based network of scientists and clinicians designed to partner with commercial organisations and accelerate the clinical development and positioning of novel cancer diagnostic and therapeutic strategies.

For more information contact:
hagen.schwenzer@medsci.ox.ac.uk

or click here to visit the CPN website.